Sub Heading

Clinical Trials Details

LSTA1 Phase 1b/2a Continuous Infusion Trial in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

IRB Protocol Number
LSTA1-P06

Clinical Trial Categories

  • Pancreas/Billiary
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Metastatic pancreatic ductal adenocarcinoma patients who have progressed on FOLFIRINOX

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.